Empfehlung
28,0
Verkaufen
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
93.9
13D-Filing vorhanden
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
Stammdaten
Unternehmen
| Name | HCA Healthcare, Inc. |
|---|---|
| Ticker | HCA |
| CIK | 0000860730 |
Branche
| SIC-Code | 8062 |
|---|---|
| Beschreibung | Services-General Medical & Surgical Hospitals, NEC |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | HCA Healthcare, Inc. |
Status
| Zuletzt geprüft | 2026-03-23 20:12:20.089051 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | McAlevey Michael R | Officer, EVP & Chief Legal & Admin Off. | Open Market Sale | -1,694 | 533.37 | -903,536.74 | -33,3% | |
| 2026-02-18 | McAlevey Michael R | Officer, EVP & Chief Legal & Admin Off. | Open Market Sale | -1,694 | 533.37 | -903,536.74 | -33,3% | |
| 2026-02-11 | Wyatt Christopher F. | Officer, SVP & Controller | Open Market Sale | -4,000 | 505.00 | -2,020,000.00 | -74,4% | |
| 2026-02-11 | Berres Jennifer | Officer, SVP & Chief Human Res. Officer | Open Market Sale | -4,010 | 503.00 | -2,017,030.00 | -74,3% | |
| 2026-02-11 | Berres Jennifer | Officer, SVP & Chief Human Res. Officer | Open Market Sale | -4,010 | 526.16 | -2,109,920.05 | -77,7% | |
| 2026-02-11 | Wyatt Christopher F. | Officer, SVP & Controller | Open Market Sale | -4,000 | 505.00 | -2,020,000.00 | -74,4% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -7,395 | 500.69 | -3,702,626.21 | -136,4% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -7,395 | 500.69 | -3,702,626.21 | -136,4% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -6,189 | 500.02 | -3,094,608.93 | -114,0% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -5,162 | 498.80 | -2,574,793.73 | -94,9% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -4,293 | 498.12 | -2,138,442.04 | -78,8% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -120 | 497.18 | -59,661.40 | -2,2% | |
| 2026-02-03 | Cuffe Michael S. | Officer, EVP and Chief Clinical Officer | Open Market Sale | -1,500 | 498.09 | -747,135.15 | -27,5% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -14,716 | 502.95 | -7,401,385.71 | -272,7% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -5,002 | 502.15 | -2,511,756.80 | -92,5% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -6,189 | 500.02 | -3,094,608.93 | -114,0% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -5,162 | 498.80 | -2,574,793.73 | -94,9% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -4,293 | 498.12 | -2,138,442.04 | -78,8% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -120 | 497.18 | -59,661.40 | -2,2% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -14,716 | 502.95 | -7,401,385.71 | -272,7% | |
| 2026-02-03 | HAZEN SAMUEL N | Director, Officer, CEO | Open Market Sale | -5,002 | 502.15 | -2,511,756.80 | -92,5% | |
| 2025-11-05 | McAlevey Michael R | Officer, EVP & Chief Legal & Admin Off. | Open Market Sale | -3,892 | 473.79 | -1,843,990.68 | -67,9% | |
| 2025-11-05 | McAlevey Michael R | Officer, EVP & Chief Legal & Admin Off. | Open Market Sale | -3,892 | 473.79 | -1,843,990.68 | -67,9% | |
| 2025-09-08 | Cuffe Michael S. | Officer, EVP and Chief Clinical Officer | Open Market Sale | -3,836 | 418.84 | -1,606,670.24 | -59,2% | |
| 2025-05-13 | Foster Jon M | Officer, EVP and COO | Open Market Sale | -15,698 | 369.32 | -5,797,660.71 | -213,6% | |
| 2025-05-13 | Foster Jon M | Officer, EVP and COO | Open Market Sale | -15,698 | 369.32 | -5,797,660.71 | -213,6% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.